RESUMEN
In the Philadelphia chromosome (Ph1) of chronic myelogenous leukemia (CML), the c-abl gene on chromosome 9 is translocated to bcr on chromosome 22. This results in the expression of a chimeric bcr-abl message that encodes the P210bcr-abl tyrosine kinase. The cells of 10% of acute lymphocytic leukemia patients (ALL) carry a cytogenetically similar Ph1 translocation. We report that Ph1-positive ALL cells express unique abl-derived tyrosine kinases of 185 and 180 kilodaltons that are distinct from the bcr-abl-derived P210 protein of CML. The appearance of the 185/180-kilodalton proteins correlates with the expression of a novel 6.5-kilobase messenger RNA. Thus, similar genetic translocations in two different leukemias result in the expression of distinct c-abl-derived products.
Asunto(s)
Leucemia Linfoide/enzimología , Leucemia Mieloide/enzimología , Proteínas Tirosina Quinasas/genética , Proteínas Proto-Oncogénicas/genética , Proto-Oncogenes , ADN de Neoplasias/genética , Humanos , Leucemia Linfoide/genética , Leucemia Mieloide/genética , Peso Molecular , Fragmentos de Péptidos/análisis , Cromosoma Filadelfia , Fosfoproteínas/genética , ARN Mensajero/genética , ARN Neoplásico/genética , Translocación GenéticaRESUMEN
The Philadelphia chromosome (Ph1) is a translocation between chromosomes 9 and 22 that is found in chronic myelogenous leukemia (CML) and a subset of acute lymphocytic leukemia patients (ALL). In CML, this results in the expression of a chimeric 8.5-kilobase BCR-ABL transcript that encodes the P210BCR-ABL tyrosine kinase. The Ph1 chromosome in ALL expresses a distinct ABL-derived 7-kilobase messenger RNA that encodes the P185ALL-ABL protein. Since the expression of different oncogene products may play a role in the distinctive presentation of Ph1-positive ALL versus CML, it is necessary to understand the molecular basis for the expression of P185ALL-ABL. Both P210BCR-ABL and P185ALL-ABL are recognized by an antiserum directed to BCR determinants in the amino-terminal region of both proteins. Antisera to BCR determinants proximal to the BCR-ABL junction in CML immunoprecipitated P210BCR-ABL but not P185ALL-ABL. Nucleotide sequence analysis of complementary DNA clones made from RNA from the Ph1-positive ALL SUP-B15 cell line, and S1 nuclease protection analysis confirmed the presence of BCR-ABL chimeric transcripts in Ph1-positive ALL cells. In Ph1-positive ALL, ABL sequences were joined to BCR sequences approximately 1.5 kilobases 5' of the CML junction. P185ALL-ABL represents the product of a BCR-ABL fusion gene in Ph1-positive ALL that is distinct from the BCR-ABL fusion gene of CML.
Asunto(s)
Leucemia Linfoide/genética , Oncogenes , Cromosoma Filadelfia , Transcripción Genética , Secuencia de Aminoácidos , Secuencia de Bases , Clonación Molecular , Humanos , Datos de Secuencia Molecular , ARN Mensajero/genéticaRESUMEN
Intrathymic injection of Moloney murine leukemia virus (Mo-MuLV)-pseudotyped bcr-abl retrovirus (bcr-abl/M) causes thymic lymphoma but only after a prolonged latent period similar to that seen after intrathymic injection of Mo-MuLV alone. Since thymomas induced by Mo-MuLV show recurring proviral integration near certain cellular proto-oncogenes, it was reasoned that if the pathogenesis of bcr-abl/M thymomas is affected by viral integration, then it may be possible to detect proviral insertion near common Mo-MuLV integration sites in bcr-abl-induced thymomas. A panel of thymomas induced by intrathymic injection of Mo-MuLV, Abelson murine leukemia virus (A-MuLV), or the bcr-abl/M virus was analyzed for proviral integration near c-myc, N-myc, Pim-1, and Mlvi-1 loci that are frequently occupied by provirus in Mo-MuLV-induced T cell lymphomas, and for integration near Ahi-1 that is often occupied in A-MuLV/M-induced pre-B cell lymphoma. As expected, thymomas induced with Mo-MuLV showed frequent rearrangements in these loci while thymomas induced with A-MuLV/M (which does not require Mo-MuLV) did not. The bcr-abl/M-induced tumors also showed recurring proviral integration near c-myc, Pim-1 and Mlvi-1, albeit at a lower frequency than seen in the Mo-MuLV tumors. Unexpectedly, four independent thymomas that were clearly of T cell origin demonstrated proviral integration within the Ahi-1 region which was previously thought to only occur in A-MuLV/M induced pre-B cell lymphoma. These observations suggest that recurring proviral insertion in c-myc, Pim-1, Mlvi-1, and Ahi-1 may provide a selective advantage for bcr-abl/M transformed T lymphoid cells. This model may provide a tool for identifying cellular genes that can cooperate with bcr-abl in lymphoid transformation.
Asunto(s)
Proteínas de Fusión bcr-abl/genética , Regulación de la Expresión Génica , Virus de la Leucemia Murina/genética , Proto-Oncogenes , Provirus/genética , Timoma/virología , Neoplasias del Timo/virología , Integración Viral , Humanos , Proto-Oncogenes MasRESUMEN
Leukemias induced with the v-abl or BCR/ABL oncogene undergo a process of tumor progression which suggests that the ABL oncogene is required but not sufficient for full transformation. In order to identify cellular changes that correlate with progression to full transformation in v-abl transformed lymphoblasts Abelson virus (A-MuLV)-infected murine bone marrow was plated over a pre-established stromal feeder layer. Shortly after A-MuLV infection, transformed lymphoblasts were poorly oncogenic, but over time, progressed in a stepwide manner to a more oncogenic state. The transformants first acquired the ability to grow efficiently in agar, but only over the feeder layer. They next progressed to efficient feeder-independent growth in liquid culture, and then to efficient feeder-independent growth in soft agar. Cell lines that reached the advanced stage of feeder-independent agar growth showed increased detection by antiphosphotyrosine Western blot of the GAP-associated p62 phosphoprotein as well as of a 55 kDa phosphoprotein while detection of the P160 v-abl phosphoprotein remained constant throughout all stages of progression. Although the identity of the p55 phosphoprotein and the mechanism by which detection of p55 and p62 phosphoproteins change on the Western blots during tumor progression are unknown, the data demonstrate that these changes strongly correlate with the stage of progression of v-abl-transformed cells and raise the possibility that these changes may play a role in tumor progression in this model.
Asunto(s)
Virus de la Leucemia Murina de Abelson/genética , Transformación Celular Neoplásica , Leucemia Experimental/etiología , Fosfoproteínas/análisis , Tirosina/metabolismo , Células 3T3 , Animales , Técnicas de Cultivo , Proteínas de Unión al ADN/análisis , Femenino , Leucemia Experimental/metabolismo , Linfocitos/química , Linfocitos/virología , Ratones , Ratones Endogámicos BALB C , Proteínas de Unión al ARN/análisisRESUMEN
The Bcr/Abl tyrosine kinase that is expressed from the Philadelphia chromosome protects leukemia cells from apoptosis caused by removal of growth factors or by cytotoxic agents and ionizing irradiation. This resistance to apoptosis is associated with a Bcr/Abl-mediated G2/M delay. Therefore, inhibiting Bcr/Abl signaling pathways should block the ability of the Bcr/Abl kinase to protect cells from apoptosis. The monoterpenes, limonene and perillyl alcohol (POH) are new anticancer agents that selectively induce apoptosis in neoplastic cells of a variety of rodent carcinoma models. Since the potential antitumor activities of monoterpenes overlap with signaling pathways affected by the Bcr/Abl kinase, POH and limonene were tested for antileukemia activity. POH, but not limonene selectively induced G0/G1 arrest followed by apoptosis in Bcr/Abl-transformed, but not nontransformed FDC.P1 and 32D myeloid cell lines. In contrast to their greater sensitivity to POH, Bcr/Abl-transformed cells were more resistant than nontransformed cells to several chemotherapy agents and ionizing irradiation. Since in Bcr/Abl-transformed cells, POH induces apoptosis associated with G0/G1 arrest, POH must activate an apoptotic pathway that is not protected by the Bcr/Abl-induced G2/M delay. Monoterpenes may represent novel agents for treating Ph+ leukemias.
Asunto(s)
Antineoplásicos/farmacología , Proteínas de Fusión bcr-abl/fisiología , Fase G1/efectos de los fármacos , Leucemia Mieloide/tratamiento farmacológico , Monoterpenos , Fase de Descanso del Ciclo Celular/efectos de los fármacos , Terpenos/farmacología , Animales , Apoptosis/efectos de los fármacos , Células COS , Línea Celular Transformada , Resistencia a Antineoplásicos , Ensayos de Selección de Medicamentos Antitumorales , Leucemia Mieloide/patología , Tolerancia a Radiación , Relación Estructura-ActividadRESUMEN
Two patients with acute nonlymphocytic leukemia (ANLL) who had normal karyotypes at diagnosis and developed the Philadelphia (Ph) translocation during leukemia relapse are described in this report. Patient 1 relapsed with Ph-positive acute leukemia, FAB classification M1. The Ig heavy chain locus and T cell receptor gamma and beta genes of relapse cells from this patient were all found to be germline configuration confirming the diagnosis of M1 acute leukemia. Patient 2 displayed a complex karyotypic evolution leading to Ph-positive M4 relapse. Ph-positive relapse specimens from both patients expressed P185BCR-ABL protein and RNA gene products that were identified serologically and by polymerase chain amplification of the BCR-ABL RNA junction. In vitro derived myeloid cell lines from relapse M1 leukemia cells of patient 1 also expressed the P185BCR-ABL protein. In two described patients, late appearance of the Ph translocation that encodes P185BCR-ABL coincided with relapse of acute leukemia. We conclude that P185BCR-ABL may be a strong indicator of Ph-positive acute leukemias.
Asunto(s)
Proteínas de Fusión bcr-abl/análisis , Leucemia Mieloide Aguda/genética , Cromosoma Filadelfia , Femenino , Expresión Génica , Humanos , Masculino , Persona de Mediana EdadRESUMEN
In hematopoietic cells, the Bcr/Abl tyrosine kinase that is encoded by the Philadelphia chromosome translocation both stimulates proliferation and activates an anti-apoptotic program that is associated with a G2/M delay upon exposure to various apoptotic stimuli. We recently reported that the monocyclic monoterpene, perillyl alcohol (POH) selectively induces in Bcr/Abl transformed cells, G0/G1 arrest and apoptosis. Therefore, POH activates anti-proliferative and apoptotic pathways against which the Bcr/Abl kinase does not protect. In this report, we show that in Bcr/Abl-transformed cells, POH induces cytoplasmic acidification, redistribution of phosphatidylserine in the plasma membrane along with DNA fragmentation, all of which can be prevented by the phorbol ester, TPA. The ability of TPA to protect against POH-induced cytotoxicity was blocked by inhibitors of protein kinase C (PKC) and the Na(+)/H(+) antiport. In contrast, TPA does not protect the cells from POH-mediated G0/G1 arrest. While POH inhibits a distal step in the mevalonate biosynthesis pathway, lovastatin, also a potential anticancer agent, inhibits the initial step in this pathway. Not surprisingly, lovastatin also induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed cells, however, TPA protects cells from both apoptosis and G0/G1 arrest caused by lovastatin. Thus, in Bcr/Abl-transformed cells, POH and lovastatin cause growth arrest by different mechanisms. Together, these observations demonstrate that POH-mediated cell cycle arrest precedes apoptosis and raises the possibility that that the primary effect of POH is to induce G0/G1 arrest with apoptosis being a consequence of the growth arrest.
Asunto(s)
Apoptosis/efectos de los fármacos , Proteínas de Fusión bcr-abl/fisiología , Fase G1/efectos de los fármacos , Monoterpenos , Células Madre Neoplásicas/efectos de los fármacos , Fase de Descanso del Ciclo Celular/efectos de los fármacos , Terpenos/farmacología , Amilorida/farmacología , Animales , Línea Celular Transformada/citología , Línea Celular Transformada/efectos de los fármacos , Línea Celular Transformada/metabolismo , Transformación Celular Neoplásica , Citoplasma/química , Fragmentación del ADN , Inhibidores Enzimáticos/farmacología , Proteínas de Fusión bcr-abl/antagonistas & inhibidores , Células Madre Hematopoyéticas/efectos de los fármacos , Concentración de Iones de Hidrógeno , Interleucina-3/farmacología , Lovastatina/farmacología , Lípidos de la Membrana/análisis , Ratones , Naftalenos/farmacología , Células Madre Neoplásicas/citología , Fosfatidilserinas/análisis , Fosforilación/efectos de los fármacos , Procesamiento Proteico-Postraduccional/efectos de los fármacos , Proteínas Recombinantes de Fusión/antagonistas & inhibidores , Proteínas Recombinantes de Fusión/fisiología , Transducción de Señal/efectos de los fármacos , Intercambiadores de Sodio-Hidrógeno/antagonistas & inhibidores , Intercambiadores de Sodio-Hidrógeno/metabolismo , Estaurosporina/farmacología , Acetato de Tetradecanoilforbol/farmacologíaRESUMEN
Cytogenetic analysis of a pediatric patient with T-cell acute lymphoblastic leukemia (T-ALL) revealed a mosaic karyotype, 47,XX,+17,t(11;14)(p13;q11)/47,XX,+17,t(9;22)(q34;q11),t(11;14) (p13;q11). DNA blot analysis was used to examine the break-point within the BCR gene on chromosome 22 and showed that the breakpoint occurred within the 20-kb minor breakpoint cluster region (m-bcr) located within the first intron of the BCR gene. Immunoprecipitation analysis demonstrated that the leukemic cells expressed the P185 BCR-ABL protein tyrosine kinase. P185 BCR-ABL has previously been shown to be expressed in most cases of Ph+ acute leukemia of myeloid and B-progenitor origin. Here, we demonstrate for the first time that P185 can also be expressed in the T-cell lineage. DNA blot hybridization was also used to characterize the t(11;14) translocation. This showed rearrangement on chromosome 11 within the T-ALLbcr region, upstream of the RBTN-2 gene. Polymerase chain reaction revealed the presence of RBTN-2 transcripts in the leukemic cells. Finally, comparison of the T-ALLbcr, BCR-ABL, IGH, TCR beta and gamma gene rearrangements in leukemic cells obtained at the time of diagnosis and at first relapse showed that relapse occurred in a leukemic clone indistinguishable from the major Ph+ clone involved at diagnosis. Together, these data support a multistep pathogenesis in which the Philadelphia (Ph) chromosome translocation appeared subsequent to the +17 and t(11;14) and imparted a growth advantage over the Ph-negative cells that carried these abnormalities.
Asunto(s)
Cromosomas Humanos Par 11 , Cromosomas Humanos Par 14 , Genes abl , Leucemia-Linfoma de Células T del Adulto/genética , Cromosoma Filadelfia , Factores de Transcripción/genética , Translocación Genética , Secuencia de Bases , Niño , ADN de Neoplasias/análisis , Proteínas de Unión al ADN , Femenino , Expresión Génica , Humanos , Immunoblotting , Inmunofenotipificación , Cariotipificación , Proteínas con Dominio LIM , Datos de Secuencia Molecular , Proteínas Oncogénicas , ARN Neoplásico/análisisRESUMEN
The attrition of Schistosoma mansoni challenge worms was studied in irradiation-attenuated cercaria-immunized mice as a function of site and time. The peak recovery of schistosomula from the lungs of immunized mice was delayed 2 days in comparison with non-immunized controls. The difference between the peak recoveries of control and immunized mice accounted for about half of the final attrition observed at the 7-week adult worm stge. Hepatic-mesenteric vein worm recoveries obtained 10 to 42 days after challenge were reduced in most cases at least as much as the 49-day counts. Somewhat higher reductions were observed at 14 to 28 days than at 49 days, confirming the evidence of delayed migration obtained at the lung phase. These findings, coupled with histologic observations, indicate that at least half of the worm elimination attributable to immunization occurs 8 or more days after the challenge infection.
Asunto(s)
Schistosoma mansoni/efectos de la radiación , Esquistosomiasis/inmunología , Animales , Femenino , Inmunización , Larva/inmunología , Larva/efectos de la radiación , Venas Mesentéricas/parasitología , Ratones , Ratones Endogámicos , Vena Porta/parasitología , Schistosoma mansoni/inmunología , Esquistosomiasis/parasitologíaRESUMEN
Acquired resistance to Schistosoma mansoni infection was measured in S. mansoni-infected or irradiated cercaria-immunized mice, and in normal mice to which the former had been surgically joined. Such parabiotic partners were shown to freely exchange humoral and cellular blood constituents. There was no detectable transfer of resistance from mice infected for 8, 12, or 28 weeks to their uninfected partners, even if parabiosis was established before the initial infection and maintained to autopsy. In comparison with parabiosed controls, the number of adult worms surviving from a challenge infection was reduced by 51-96% in the previously infected mice but was not significantly reduced in their uninfected partners. In contrast, mice immunized with irradiated cercariae and their nonimmunized parabiotic partners showed similar levels of resistance. These data indicate that the resistance induced in mice by irradiated cercariae can be transferred, confirm that at least under some experimental conditions the resistance induced in mice by a previous S. mansoni infection is not readily transferred, and provide additional evidence that the resistance induced by normal infection and irradiated cercarial immunization differ in some fundamental way.
Asunto(s)
Inmunización Pasiva/métodos , Parabiosis , Esquistosomiasis/inmunología , Animales , Femenino , Larva/inmunología , Larva/efectos de la radiación , Ratones , Schistosoma mansoni/inmunologíaRESUMEN
A case of fibroma of the tunica albuginea is presented with a review of the literature on previously reported cases of this rare entity. The characteristics of this lesion, its pathogenesis, and its treatment are considered.
Asunto(s)
Calcinosis/patología , Fibroma/patología , Neoplasias Testiculares/patología , Adulto , Calcinosis/cirugía , Castración , Fibroma/cirugía , Humanos , Masculino , Neoplasias Testiculares/cirugíaRESUMEN
Two patients with large calculi in solitary kidneys, treated by ex vivo stone extraction and autotransplantation, are presented. The results show this to be a valuable therapeutic modality for difficult renal calculi where an in situ approach would be hazardous.
Asunto(s)
Cálculos Renales/cirugía , Nefrectomía , Reimplantación , Adulto , Femenino , Humanos , Hipotermia Inducida , Riñón/diagnóstico por imagen , Cálculos Renales/diagnóstico por imagen , Masculino , Persona de Mediana Edad , Perfusión , Radiografía , Factores de TiempoRESUMEN
A high-performance liquid chromatographic method with amperometric detection utilizing oxidation at the glassy carbon electrode is reported for the quantitative determination of a guanethidine (1)-hydrochlorothiazide (2) mixture. The drug mix is difficult to analyze by a single assay procedure due to large differences in the chemistry and chemical structure of the compounds. The drugs are best separated on an octadecylsilane column using 30:70 acetonitrile:0.05 M aqueous sodium dihydrogen phosphate containing 0.02 M sodium pentanesulfonate (pH 2.5) as the mobile phase at a 1.0 mL/min flow rate. Using a cell potential of +1300 mV versus Ag/AgCl and procaine hydrochloride as the internal standard, calibration curves were established for 1 monosulfate or sulfate and 2 in the 0.5-10 and 1.25-25 micrograms/mL range, respectively. Accuracy and precision of the assay are in the 1.7-6% range. The procedure is shown applicable to the analysis of a combination dosage form and is also useful for either drug in a single component dosage form.
Asunto(s)
Guanetidina/análisis , Hidroclorotiazida/análisis , Cromatografía Líquida de Alta Presión , Combinación de Medicamentos , Electroquímica , ComprimidosRESUMEN
Data presented here describe recent attempts to understand the structural basis for H-2 function. Inbred strains differing only by point mutation in different regions of H-2Kb have proven valuable in the analysis of H-2 domain function. Evidence for the interaction between the N and C1 domains in forming allorecognition determinants and antigen interaction sites is shown. The functional role of C2 is not yet known, since no mutations have been found there, but DNA-mediated gene transfer and exon shuffling techniques should prove invaluable in addressing this issue. Ir gene-type functions of class I molecules were demonstrated. The inability of low responder mutant strains to cross-react with H-2Kb-restricted CTL suggests that these phenomena reflect the failure of virus antigen to interact with low responder H-2Kbm molecules. Thus, the mutant strains provide a valuable system for investigating class I Ir genes.